Sign in
4

Changes in Ownership

Vivos Therapeutics, Inc. Filed Acc 0001493152-21-021915

Options or other derivatives

  • Chief Financial Officer acquired 250,001 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Amman Bradford K. Chief Financial Officer 2021-08-31 Grant or award · Stock Option (Right to Buy) +50,000 $5.26 $263,000 50,000 D
Amman Bradford K. Chief Financial Officer 2021-03-12 Grant or award · Stock Option (Right to Buy) +100,000 $7.50 $750,000 100,000 D
Amman Bradford K. Chief Financial Officer 2019-11-18 Grant or award · Stock Option (Right to Buy) +16,667 $7.50 $125,003 16,667 D
Amman Bradford K. Chief Financial Officer 2018-10-22 Grant or award · Stock Option (Right to Buy) +83,334 $7.50 $625,005 83,334 D
Loading xslF345X03/ownership.xml…